Manufacturers:

Innovative therapies deserve modern access infrastructure.

Zeal partners with pharmaceutical and biotechnology companies to support therapy access, patient engagement, and specialized distribution models across rare disease, specialty, and specialty-lite therapies.

How Zeal supports manufacturers

• Accelerate therapy access through benefits investigation and authorization support
• Engage patients with education, adherence monitoring, and coordinated care
• Support distribution strategies for complex and specialty medications
• Provide operational infrastructure for therapies entering the specialty ecosystem

Built for evolving therapies

As more treatments require specialty distribution and coordinated patient support, Zeal provides the infrastructure needed to help therapies reach patients efficiently and responsibly.

Breakthrough therapies change lives. We help patients access them.